Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › MARLBOROUGH › MARLBOROUGH HOSPITAL CORP

MARLBOROUGH HOSPITAL CORP

NPI: 1396738159 · MARLBOROUGH, MA 01752 · Community Health Clinic/Center · NPI assigned 08/26/2005

$26.78M
Total Medicaid Paid
630,914
Total Claims
510,783
Beneficiaries
208
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMCCUE, STEVEN (CFO)
NPI Enumeration Date08/26/2005

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 67,581 $3.20M
2019 74,259 $2.96M
2020 73,742 $2.82M
2021 109,893 $3.83M
2022 108,542 $4.51M
2023 106,884 $5.10M
2024 90,013 $4.36M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
96361 Intravenous infusion, hydration; each additional hour 13,002 11,336 $4.67M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 25,372 22,843 $4.51M
99283 Emergency department visit for the evaluation and management, moderate severity 23,068 21,560 $3.40M
99284 Emergency department visit for the evaluation and management, high severity 20,930 19,301 $3.14M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 31,357 9,662 $1.67M
74177 Computed tomography, abdomen and pelvis; with contrast material 6,049 5,745 $935K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 7,488 7,088 $868K
S9485 Crisis intervention mental health services, per diem 1,490 889 $728K
99282 Emergency department visit for the evaluation and management, low to moderate severity 5,131 4,938 $721K
70450 Computed tomography, head or brain; without contrast material 4,643 4,260 $500K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 3,726 3,472 $408K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 6,411 5,824 $389K
G0378 Hospital observation service, per hour 3,686 2,989 $346K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,838 2,497 $307K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 15,747 5,741 $288K
97161 4,589 4,438 $261K
77063 Screening digital breast tomosynthesis, bilateral 3,863 3,804 $243K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,838 4,405 $231K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,599 1,532 $216K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 39,144 31,568 $175K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1,115 1,081 $147K
76705 Ultrasound, abdominal, real time with image documentation; limited 1,511 1,451 $141K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 8,339 7,524 $136K
71260 Computed tomography, thorax, diagnostic; with contrast material 1,401 1,326 $127K
71046 Radiologic examination, chest; 2 views 11,388 10,613 $110K
93975 933 904 $96K
84484 14,567 9,448 $90K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,317 1,006 $70K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 465 447 $70K
ATP14 7,521 6,306 $66K
ATP08 9,010 7,279 $64K
77067 Screening mammography, bilateral, including computer-aided detection 3,879 3,823 $62K
0001A 2,323 1,468 $61K
0002A 2,186 1,358 $58K
70496 432 400 $55K
80048 Basic metabolic panel (calcium, ionized) 24,338 19,434 $52K
76830 Ultrasound, transvaginal 861 837 $50K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3,074 2,841 $49K
80053 Comprehensive metabolic panel 18,444 15,689 $49K
81025 7,093 6,662 $48K
83690 9,614 8,663 $47K
83735 11,178 8,967 $43K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 13,200 12,105 $42K
93971 252 236 $41K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,165 1,053 $40K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,083 2,993 $38K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,371 1,325 $35K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,370 1,324 $35K
76770 213 205 $32K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 495 483 $31K
87086 Culture, bacterial; quantitative colony count, urine 5,722 5,337 $31K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1,626 862 $26K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 903 803 $26K
84443 Thyroid stimulating hormone (TSH) 3,242 3,090 $24K
84703 4,164 3,947 $24K
76642 400 334 $23K
81001 10,253 9,506 $23K
87631 201 196 $21K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 17,045 14,609 $18K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,997 2,555 $18K
ATP15 2,418 1,857 $17K
83605 2,652 2,016 $16K
J1650 Injection, enoxaparin sodium, 10 mg 2,079 1,202 $16K
36415 Collection of venous blood by venipuncture 43,983 32,897 $16K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 27 27 $16K
71045 Radiologic examination, chest; single view 4,394 4,050 $15K
87088 2,642 2,484 $15K
96375 Therapeutic injection; each additional sequential IV push 8,069 7,336 $15K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,093 636 $15K
0012A 580 427 $14K
87081 2,531 2,444 $14K
83880 871 801 $13K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 214 208 $13K
87040 2,203 1,097 $13K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,934 2,613 $12K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 968 940 $12K
93017 155 148 $12K
83036 Hemoglobin; glycosylated (A1C) 2,753 2,620 $12K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,157 1,018 $11K
0011A 532 396 $11K
82962 7,927 3,267 $11K
85027 3,501 2,937 $10K
84702 855 735 $10K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 9,408 8,675 $10K
81003 6,234 5,887 $10K
85379 1,377 1,305 $10K
J2405 Injection, ondansetron hydrochloride, per 1 mg 9,332 7,656 $9K
73630 1,281 1,158 $9K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 85 81 $9K
72125 Computed tomography, cervical spine; without contrast material 1,422 1,281 $8K
74176 Computed tomography, abdomen and pelvis; without contrast material 90 85 $8K
70498 423 396 $8K
85610 3,849 2,786 $8K
J1790 Injection, droperidol, up to 5 mg 430 379 $7K
97530 Therapeutic activities, direct patient contact, each 15 minutes 375 281 $6K
J1885 Injection, ketorolac tromethamine, per 15 mg 9,449 7,995 $6K
80061 Lipid panel 3,300 3,173 $6K
73130 608 529 $5K
97162 80 79 $5K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 13 12 $5K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,666 1,530 $5K
73030 602 549 $5K
87077 955 904 $5K
72100 313 302 $5K
71250 186 174 $4K
87186 740 694 $4K
73610 983 914 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,575 1,442 $4K
J2060 Injection, lorazepam, 2 mg 1,015 799 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 15 15 $4K
J2270 Injection, morphine sulfate, up to 10 mg 4,042 3,088 $4K
86850 651 621 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,737 1,973 $4K
80050 General health panel 192 187 $3K
87210 461 419 $3K
86803 435 418 $3K
76641 45 26 $3K
12001 12 12 $3K
73110 293 269 $3K
97014 55 27 $2K
82607 405 378 $2K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 13 13 $2K
76882 13 13 $2K
96376 740 686 $2K
82803 161 141 $2K
76536 25 25 $2K
77080 56 55 $2K
82728 283 275 $2K
77065 Tomosynthesis, mammo 49 48 $2K
86140 691 609 $2K
J2704 Injection, propofol, 10 mg 2,923 2,497 $2K
A9270 Non-covered item or service 2,781 1,284 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 724 649 $2K
80076 2,905 2,623 $2K
90714 81 78 $1K
86901 786 748 $1K
86900 774 736 $1K
73562 680 588 $1K
76870 12 12 $1K
J3010 Injection, fentanyl citrate, 0.1 mg 2,115 1,925 $1K
77066 Tomosynthesis, mammo 56 56 $1K
85652 786 728 $1K
84439 257 243 $972.91
0031A 50 34 $963.27
ATP17 199 193 $895.62
82570 485 448 $888.02
71271 28 28 $849.88
83540 280 267 $836.39
88305 Level IV - Surgical pathology, gross and microscopic examination 1,224 1,120 $797.07
90686 74 66 $766.87
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 591 347 $674.80
83550 167 160 $668.71
77062 13 13 $651.48
82077 632 572 $618.01
ATP03 135 126 $498.40
73502 102 88 $441.04
84153 80 80 $400.86
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,362 1,176 $399.50
82746 58 52 $394.38
97535 Self-care/home management training, each 15 minutes 12 12 $341.38
80179 68 65 $319.60
J7050 Infusion, normal saline solution, 250 cc 2,289 1,769 $302.57
J0690 Injection, cefazolin sodium, 500 mg 308 261 $302.40
85730 101 92 $263.60
J1100 Injection, dexamethasone sodium phosphate, 1 mg 864 796 $261.67
84100 2,198 1,571 $248.41
97116 19 12 $236.33
J3475 Injection, magnesium sulfate, per 500 mg 312 280 $227.32
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 12 12 $212.40
80143 71 64 $172.70
87070 24 24 $121.68
82043 70 68 $119.18
J1644 Injection, heparin sodium, per 1000 units 22 12 $94.60
86618 12 12 $93.18
90791 Psychiatric diagnostic evaluation 25 25 $82.04
74019 15 12 $75.61
ATP11 12 12 $73.92
77091 29 28 $67.68
ATP10 12 12 $54.54
87205 12 12 $35.20
J1170 Injection, hydromorphone, up to 4 mg 153 95 $32.47
J2765 Injection, metoclopramide hcl, up to 10 mg 1,467 1,266 $27.64
82550 127 106 $11.88
76376 371 337 $0.00
73590 12 12 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 832 652 $0.00
J7030 Infusion, normal saline solution , 1000 cc 236 141 $0.00
82248 12 12 $0.00
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg 41 36 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 94 81 $0.00
91300 4,046 2,150 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 62 53 $0.00
84460 41 41 $0.00
J8499 Prescription drug, oral, non chemotherapeutic, nos 108 44 $0.00
84450 28 28 $0.00
73080 13 13 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 19 12 $0.00
S0164 Injection, pantoprazole sodium, 40 mg 18 13 $0.00
80069 39 36 $0.00
91301 763 474 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 16 15 $0.00
94761 85 82 $0.00
76801 16 15 $0.00
91303 45 29 $0.00
88304 14 13 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 14 13 $0.00
J1815 Injection, insulin, per 5 units 15 12 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 15 12 $0.00